The MEQ peptide vaccine elicits strong immune responses via epitope selection, highlighting its potential in infectious disease prevention.
Amino Acid Sequence: The MEQ Peptide Vaccine is composed of a sequence of epitopes from the pathogen’s antigens, designed to elicit a strong immune response. The peptide sequences are selected based on their ability to bind major histocompatibility complex (MHC) molecules and stimulate T-cells and B-cells. Modifications: The peptides may be modified with adjuvants or carrier proteins to enhance immunogenicity. Additionally, conjugation with lipids or polymers can improve stability and delivery efficiency.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: